Rhodococcus equi: PCR Detection and Zoonotic Overview

Rhodococcus equi belongs to the phylum Actinobacteria, class Actinobacteria, order Actinomycetales, family Nocardiaceae, and genus Rhodococcus.

The organism was first isolated from foals with pneumonia, and its name reflects both its equine association and its ability to produce reddish colonies due to carotenoid pigments.

Rhodococcus equi is a Gram-positive bacterium, although it may appear Gram-variable due to its lipid-rich cell wall.

In young cultures, it appears as coccoid or short rods, while older cultures may show filamentous or branching forms.

It exhibits weak acid-fast staining, a characteristic similar to Mycobacterium species.

The bacterium is aerobic and grows optimally at 30–37°C.

Growth on blood agar is relatively slow, typically requiring 48–72 hours for visible colony formation.

Colonies are smooth, moist, and vary in color from gray-white to pale yellow, with some strains producing characteristic red pigmentation.

These features assist in preliminary identification in laboratory settings.

Rhodococcus equi is a well-known cause of pneumonia in foals and is a major veterinary concern.

In humans, infection primarily occurs in immunocompromised individuals, including patients with HIV/AIDS, transplant recipients, and those receiving immunosuppressive therapy.

Pulmonary infection is the most common manifestation, often resembling tuberculosis, with symptoms such as chronic cough, fever, and lung abscess formation.

Extrapulmonary infections, including bacteremia and abscess formation in various organs, may also occur.

Diagnosis typically involves culture, microscopy, and biochemical testing.

Due to its slow growth and similarity to other actinomycetes, molecular methods are increasingly used for accurate identification.

Real-time PCR (qPCR) enables rapid, sensitive, and specific detection of Rhodococcus equi, making it valuable for both clinical diagnostics and veterinary surveillance.

Molecular tools also support epidemiological studies and monitoring of zoonotic transmission.

Preventive measures in veterinary settings include environmental management to reduce exposure, particularly in horse breeding facilities.

In humans, minimizing exposure to contaminated soil and animal environments is important, especially for immunocompromised individuals.

Proper hygiene and infection control practices are essential to reduce transmission risk.